Specialty Enzymes Market

Report Code FB 2276
Published in Jul, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029

Overview

According to MarketsandMarkets, the global Specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%. The growth of specialty enzymes is fueled by increasing demand for effective biocatalysts in pharmaceuticals and diagnostics drives innovation and market expansion. Advancements in biotechnology and genetic engineering enable the development of more efficient and specific enzymes, broadening their application scope. Additionally, investment in healthcare and biopharmaceuticals is increasing, supporting the use of specialty enzymes in developing new therapies and drug formulations. As consumers become more health-conscious, the use of specialty enzymes in nutraceuticals and functional foods is also on the rise, further propelling market growth. The expanding business has offered lucrative business opportunities to the players who are operating in the market segments. For instance, in February 2024, New England Biolabs (US) launched the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq), an enzyme-based method for the specific detection of 5hmC sites, offering high yields and quality data from inputs ranging from 100 pg to 200 ng. By enabling the specific detection of 5hmC, NEB strengthens its position in the enzyme market, providing researchers with advanced tools for epigenetic studies and gene regulation research. Other major players, such as Sekisui Diagnostics (US) announced a USD 16.4 million investment to expand cGMP microbial capacity at its Maidstone, Kent site, slated for completion in the second half of 2022. This followed a USD 1.9 million investment in a new Bioprocess Innovation Centre completed in October 2019. This strategic expansion significantly enhanced Sekisui's capabilities in the specialty enzyme market, enabling them to meet growing demand and solidify their position in the microbial biopharma CDMO sector.

Attractive Opportunities in the Specialty Enzymes Market

Asia Pacific

The growth in the Asia Pacific specialty enzymes market is driven by increased pharmaceutical R&D, diagnostic advancements, and rising healthcare investments.

The specialty enzymes market is growing due to increased demand for biocatalysts in drug development and disease diagnosis.

Asia Pacific is the fastest-growing region for the specialty enzymes market with a CAGR of 10.20%.

Acquisitions and product launches would offer lucrative opportunities for market players.

The specialty enzymes market in the pharmaceutical industry is growing due to increased drug production efficiency, biocatalysts advancements, and rising demand for biopharmaceuticals.

Global Specialty Enzymes Market Dynamics

Drivers: Supportive Government Policies and Funding

Public funding and incentives for biotechnological research can drive growth and innovation in the specialty enzymes market. The EU's Horizon Europe program, with a budget of USD 103.6 billion for 2021-2027, focuses on research and innovation, including biotechnology, supporting projects aimed at developing advanced biotechnological processes and products. In the United States, the National Institutes of Health (NIH) allocated over USD 42.0 billion for biomedical research in 2022, with part of this funding directed towards biotechnology research, including developing novel enzymes for medical and industrial applications. India's Biotechnology Industry Research Assistance Council (BIRAC) also provides funding and support for biotech startups and research institutions, fostering innovation in enzyme technology through initiatives like the Biotechnology Ignition Grant (BIG) scheme.One noteworthy government initiative aimed at fostering innovation and growth in the specialty enzymes market, particularly within biotechnology and pharmaceuticals, is the Biotechnology Industry Research Assistance Council (BIRAC) in India. Established by the Department of Biotechnology (DBT), Government of India, BIRAC actively supports biotech startups and research institutions through various funding schemes. Among these initiatives is the Biotechnology Ignition Grant (BIG) scheme, which provides early-stage funding to startups and entrepreneurs with innovative ideas in biotechnology. In July 2020, BIRAC allocated Rs. 50 crores (USD 6.7 million approximately) under the BIG scheme to support approximately 100 startups and entrepreneurs in the biotechnology sector. This funding injection aims to catalyze innovation, encourage entrepreneurship, and accelerate the development of novel enzyme-based solutions for various applications in biotechnology and pharmaceuticals. By providing financial support and fostering a conducive ecosystem for research and development, initiatives like BIRAC's BIG scheme contribute to the growth and competitiveness of the enzyme market in India..

Restraints: High Costs Limiting Specialty Enzymes Market Adoption and Growth

The production of specialty enzymes often involves advanced biotechnological methods, such as recombinant DNA technology, protein engineering, and fermentation processes. These methods require state-of-the-art equipment and highly skilled personnel, which contribute to the overall cost. For example, the production of recombinant enzymes involves the use of genetically modified microorganisms, which must be carefully cultivated, maintained, and controlled to ensure consistent enzyme quality and activity.The high production costs of specialty enzymes translate to higher prices for end-users in industries such as pharmaceuticals, food and beverages, and biotechnology. This price premium can be a significant barrier to adoption, especially for small and medium-sized enterprises (SMEs) that may not have the financial resources to invest in these high-cost inputs. In the pharmaceutical industry, enzymes are used in drug formulation and production processes. The high cost of these enzymes can significantly impact the overall cost of drug development and manufacturing. For instance, the cost of enzymes used in biocatalysis can account for up to 30% of the total production cost of certain pharmaceuticals. This cost factor can influence the pricing of the final pharmaceutical products, potentially making them less competitive in the market.

Opportunities: Technological Innovations and Wide Industry Scope

A new number of specialty applications of enzymes are being developed to enhance production processes. Several companies in the pharmaceutical industry are incorporating the use of enzymes as an alternative to chemicals to produce drugs with negligible side effects. Gene modification in the existing enzyme has resulted in significant development to enable enzymes to be functional under varying temperatures and pH levels. Specialty enzymes have been commonly used in biotechnology developments to duplicate and insert DNA when required in genetic engineering techniques. Due to advancements in research & biotechnology, the time-efficient diagnosis of various chronic diseases such as cancer, cardiovascular diseases, and lysosomal abnormalities has been found. Research institutes are focusing on high investments in R&D and discovering new applications such as drug cloning and gene modifications.Here are some examples:In November 2023, BRAIN Biotech's interdisciplinary project teams,s comprising experts in microbiology, molecular biology, and bioprocess development, optimized an Aspergillus Niger strain for efficient enzyme and alternative protein production, achieving yields in the double-digit gram-per-liter range. This innovation positions BRAIN Biotech AG to significantly advance in the specialty enzyme market by replacing a large proportion of animal proteins with sequence-identical, microbially produced proteins, enhancing sustainability and efficiency.In May 2023, Codexis, Inc. announced the launch of its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis technology, a new platform for manufacturing RNA oligonucleotide therapeutics at scale. This proprietary technology replaces traditional phosphoramidite chemistry with enzymatic methods, enabling scalable, sustainable production designed to overcome existing manufacturing challenges.

Challenges: High Research and Development Costs

High research and development (R&D) costs are a significant barrier for companies, especially smaller ones, looking to enter the specialty enzymes market. The development of new enzymes requires substantial investments in research, laboratory equipment, personnel, and clinical trials. These expenses can be prohibitive for smaller companies with limited financial resources, thus limiting innovation and competition within the market.The Pharmaceutical Research and Manufacturers of America (PhRMA) indicates that the pharmaceutical industry's R&D spending reached approximately USD 83.0 billion in 2020 (source: PhRMA Annual Membership Survey, 2020).Novozymes A/S (Denmark) is a global leader in the production of enzymes and microorganisms. The company invests heavily in R&D to drive innovation and develop new enzyme solutions tailored to various industries, including agriculture, food and beverages, bioenergy, and household care. As of their Annual Report 2023, Novozymes allocated approximately 11.27% of its revenue (approximately USD 290 million) to research and development activities. This substantial investment enables Novozymes to maintain its competitive edge by continuously introducing new products and improving existing ones.

Global Specialty Enzymes Market Ecosystem Analysis

ECOSYSTEM ANALYSIS The supply side of the specialty enzymes market encompasses a diverse ecosystem of stakeholders involved in the production, distribution, and sale of specialty enzymes. At the core of this ecosystem are enzymes manufacturers, ranging from large multinational corporations to small and medium-sized enterprises (SMEs), which develop and produce specialty enzymes for various industries and applications. These manufacturers rely on a network of suppliers for raw materials, enzymes-producing organisms, and laboratory equipment to support their production processes.

Proteases is projected to be the fastest-growing segment in the enzyme market during the forecast period.

Proteases have extensive applications in pharmaceuticals, biotechnology, and healthcare. In the pharmaceutical sector, they are crucial for drug formulation and therapeutic treatments, including anti-inflammatory and anticancer drugs, due to their ability to break down proteins into peptides and amino acids. In biotechnology, proteases are vital for protein sequencing, peptide synthesis, and various molecular biology applications, driven by the demand for precise tools in genetic research and biotechnological advancements. In healthcare, they play a significant role in wound care and digestive health products, improving patient outcomes through enzymatic debridement and digestive supplements. Advancements in genetic engineering have further enhanced the efficiency and specificity of proteases, making them indispensable across these sectors.

Microorganism-based specialty enzymes are projected to experience the fastest growth in the forecasted period

This trend is primarily driven by advancements in biotechnology and microbial fermentation techniques, which have significantly enhanced the production efficiency and diversity of enzymes derived from microorganisms. Microbial sources such as bacteria and fungi offer several advantages over traditional plant and animal sources, including higher enzyme yields, faster production times, and the ability to modify enzyme characteristics through genetic engineering. Moreover, the increasing demand for sustainable and eco-friendly manufacturing processes has boosted the adoption of microorganism-based enzymes. These enzymes are often more cost-effective and scalable, making them ideal for large-scale specialty applications in sectors such as research & biotechnology, biocatalysts, diagnostics, and pharmaceuticals. Their versatility allows for the development of enzymes tailored to specific industrial needs, such as thermostable enzymes for high-temperature processes or enzymes with enhanced substrate specificity.

Asia Pacific Region Holds the Largest Share of the Specialty Enzymes Market.

The region's pharmaceutical and biotechnology sectors are also expanding rapidly. According to the India Brand Equity Foundation, 2023, India's pharmaceutical industry, which contributes over 20% of the global generics market, relies heavily on enzymes for drug production.

Recent Developments of Specialty Enzymes Market industry

  • In March 2024, Biocatalysts, part of the BRAIN Biotech Group, enhanced its production capacity by adding a large-scale freeze-drying facility at its Cardiff site. This new facility would support the customization and precise formulation of enzymes for the food, beverage, and life sciences industries. By complying with kosher, halal, ISO9001:2015, and FSSC22000 standards, the facility ensured high-quality and flexible enzyme production..
  • In March 2024, Sanofi India Limited (SIL) approved an agreement with Emcure Pharmaceuticals to exclusively distribute and promote SIL’s Cardiovascular products in India. While SIL retains ownership, import, and manufacturing, Emcure would enhance engagement with healthcare professionals and broaden the reach, benefiting patients nationwide and strengthening Sanofi’s market presence.

Key Market Players

KEY PLAYERS IN THE Specialty Enzymes Market INCLUDE

  • BRAIN Biotech AG (Germany)
  • Novozymes A/S (Denmark)
  • Codexis, Inc. (US)
  • Sanofi (France)
  • Merck - The Vibrant Science & Technology Company
  • Dyadic International Inc (US)
  • Advanced Enzyme Technologies (India)
  • Amano Enzyme Inc (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • New England Biolabs (US)
  • BBI Solutions (UK)
  • Creative Enzymes (US)
  • Bioseutica (Netherland)
  • SEKISUI Diagnostics (US)

Want to explore hidden markets that can drive new revenue in Specialty Enzymes Market?

Scope of the Report

Report Attribute Details
Market size estimation 2024–2029
Base year considered 2023
Forecast period considered 2024–2029
Units considered Value (USD)
Segments Covered By Type, By Source, By application, By Form and Region.
Regions covered North America, Europe, Asia Pacific, South America, and Rest of the World
Companies studied BRAIN Biotech AG (Germany)

 

Key Questions Addressed by the Report

What are the key product types considered in the study for specialty enzymes, and which segments within North America’s enzyme type are projected to experience promising growth?
The study focuses on three major product types: Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other Enzymes. Within North America’s enzyme type, the subsegment Carbohydrases emerges as the dominant category, showcasing promising growth potential in the projected market trends.
Is there customizable information available specific to the North America specialty enzymes market, and if so, what details are provided?
Yes, Certainly, customization options are available for the North America specialty enzymes market across different segments, encompassing market size, dynamics, forecasts, competitive landscape, and company profiles. Exclusive insights will be offered for the specified North America countries below:
US
Canada
Could you highlight the opportunities identified in the study that are expected to fuel the future growth of the Specialty enzymes market?
The global Specialty enzymes market is characterized by the following opportunities:
Growth in Personalized Medicine: The specialty enzymes market is set to benefit from the increasing demand for personalized medicine. Enzymes are crucial in developing targeted therapies, leading to higher efficacy and fewer side effects, driving market growth and innovation.
Advancements in Diagnostic Technologies: The specialty enzymes market benefits from advancements in diagnostic technologies. Enzymes such as reverse transcriptase and polymerases are essential in developing innovative diagnostic tools, including rapid COVID-19 tests and other infectious disease diagnostics, propelling market growth.
Among the regions studied, which one is anticipated to exhibit the CAGR for the Specialty enzymes market?
Asia Pacific is the fastest-growing market for specialty enzymes due to the rapid expansion of its pharmaceutical and biotechnology sectors, with increasing healthcare expenditure. The region benefits from favorable government policies and significant investments in research and development. Additionally, the rising prevalence of chronic diseases and the demand for advanced medical diagnostics drive the market growth. Countries like China, India, and Japan are leading this expansion, making the Asia Pacific a key region for specialty enzyme development.
How is the competitive landscape structured in the specialty enzymes market?
The market is consolidated, with major players like Novozymes A/S (Denmark), Sanofi (France) and Merck KGaA (Germany) holds significant shares. These companies leverage extensive product portfolios, strategic partnerships, and substantial R&D investments to maintain their market positions. .

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Specialty Enzymes Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
33
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
54
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    INCREASE IN RETAIL SALES
    GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA
  • 5.3 MARKET DYNAMICS
    DRIVERS
    - Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics
    - Supportive government policies and funding
    - Advanced tools to optimize pharmaceutical production
    RESTRAINTS
    - Lack of harmonization in regulatory framework
    - High costs associated with specialty enzymes
    OPPORTUNITIES
    - Rising significance of catalysts in pharmaceutical industry
    - Technological innovations and wide industry scope
    - Development of enzymes with long shelf life
    - Need for encapsulation to enhance shelf life of enzymes
    - Utilization of plant biomass for production of specialty enzymes
    CHALLENGES
    - High research and development costs
    - Competition from alternative technologies or products
INDUSTRY TRENDS
68
  • 6.1 INTRODUCTION
  • 6.2 SUPPLY CHAIN ANALYSIS
  • 6.3 VALUE CHAIN ANALYSIS
  • 6.4 TRADE ANALYSIS
    EXPORT SCENARIO OF SPECIALTY ENZYMES
    IMPORT SCENARIO OF SPECIALTY ENZYMES
  • 6.5 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Protein engineering for drug delivery
    - Next-Generation Sequencing (NGS) for enzyme-based diagnostics
    - Directed evolution of enzymes
    ADJACENT TECHNOLOGIES
    - Food enzymes immobilization
  • 6.6 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
  • 6.7 ECOSYSTEM
    SUPPLY SIDE
    DEMAND SIDE
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 6.9 PATENT ANALYSIS
  • 6.10 KEY CONFERENCES & EVENTS, 2024–2025
  • 6.11 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATIONS, BY REGION
    - North America
    - Europe
    - Asia Pacific
    - South America
  • 6.12 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 6.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 6.14 CASE STUDIES
    BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
    CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
    THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
  • 6.15 INVESTMENT AND FUNDING SCENARIO
SPECIALTY ENZYMES MARKET, BY TYPE
91
  • 7.1 INTRODUCTION
  • 7.2 CARBOHYDRASES
    APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
    AMYLASES
    CELLULASES
    OTHER CARBOHYDRASES
  • 7.3 PROTEASES
    INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET
  • 7.4 LIPASES
    USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET
  • 7.5 POLYMERASES & NUCLEASES
    PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH
  • 7.6 OTHER ENZYMES
SPECIALTY ENZYMES MARKET, BY FORM
108
  • 8.1 INTRODUCTION
  • 8.2 LIQUID
    NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES
  • 8.3 DRY
    ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH
SPECIALTY ENZYMES MARKET, BY SOURCE
110
  • 9.1 INTRODUCTION
  • 9.2 MICROORGANISMS
    NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET
  • 9.3 PLANTS
    ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT
  • 9.4 ANIMALS
    ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES
SPECIALTY ENZYMES MARKET, BY APPLICATION
117
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICALS
    INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET
  • 10.3 RESEARCH & BIOTECHNOLOGY
    DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET
  • 10.4 DIAGNOSTICS
    SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH
  • 10.5 BIOCATALYSTS
    BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES
SPECIALTY ENZYMES MARKET, BY REGION
129
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT ANALYSIS
    US
    - Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market
    CANADA
    - Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics
    MEXICO
    - Need for detecting changes in substrate concentrations to boost market growth
  • 11.3 EUROPE
    EUROPE: RECESSION IMPACT ANALYSIS
    ITALY
    - Rise in production of pharmaceuticals to drive demand for specialty enzymes
    GERMANY
    - Rapid technological advancements in pharmaceuticals sector to boost growth
    FRANCE
    - Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes
    SPAIN
    - Spanish government’s emphasis on developments in pharmaceutical industry to boost enzymes market
    UK
    - Increased use of enzymes in drug cloning technique to spur demand
    DENMARK
    - Growing export of enzymes to propel demand for specialty enzymes
    NETHERLANDS
    - Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    CHINA
    - Rapid technical advancements to augment demand for specialty enzymes
    INDIA
    - Rising demand for specialty enzymes in pharmaceutical industry to boost market
    JAPAN
    - Growing biotechnology advancements in Japan to augment demand for specialty enzymes
    SOUTH KOREA
    - Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes
    AUSTRALIA & NEW ZEALAND
    - Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes
    REST OF ASIA PACIFIC
  • 11.5 SOUTH AMERICA
    SOUTH AMERICA: RECESSION IMPACT
    BRAZIL
    - Thriving pharmaceutical industry to drive demand for enzymes
    ARGENTINA
    - Government support in pharmaceuticals and research and development to boost growth
    REST OF SOUTH AMERICA
  • 11.6 REST OF THE WORLD
    REST OF THE WORLD: RECESSION IMPACT ANALYSIS
    AFRICA
    - Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry
    MIDDLE EAST
    - Government initiatives to promote biotechnological research and development to drive demand
COMPETITIVE LANDSCAPE
197
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 BRAND/PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    OTHERS
COMPANY PROFILES
222
  • 13.1 KEY PLAYERS
    BRAIN BIOTECH AG
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NOVOZYMES A/S
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    CODEXIS, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SANOFI
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    DYADIC INTERNATIONAL INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ADVANCED ENZYME TECHNOLOGIES
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    AMANO ENZYME INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NEW ENGLAND BIOLABS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    BBI SOLUTIONS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    CREATIVE ENZYMES
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    BIOSEUTICA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SEKISUI DIAGNOSTICS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ANTOZYME BIOTECH PVT. LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
  • 13.2 OTHER PLAYERS
    S.I. BIOZYME
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    AUMGENE BIOSCIENCES
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ENZYME BIOSCIENCE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    INFINITA BIOTECH PRIVATE LIMITED
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    BIOLAXI ENZYMES PVT. LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    FIDO PHARMA PVT. LTD.
    4BASEBIO
    ANSEL BIOTECH
    GENO TECHNOLOGY INC.
    GUJARAT ENZYME
ADJACENT AND RELATED MARKETS
278
  • 14.1 INTRODUCTION
  • 14.2 LIMITATIONS
  • 14.3 INDUSTRIAL ENZYMES MARKET
    MARKET DEFINITION
    MARKET OVERVIEW
  • 14.4 FOOD ENZYMES MARKET
    MARKET DEFINITION
    MARKET OVERVIEW
    FOOD ENZYMES MARKET, BY APPLICATION
    FOOD ENZYMES MARKET, BY REGION
  • 14.5 FEED ENZYMES MARKET
    MARKET DEFINITION
    MARKET OVERVIEW
APPENDIX
286
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 USD EXCHANGE RATES, 2020–2023
  • TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029
  • TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
  • TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
  • TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020–2023 (USD/KG)
  • TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
  • TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM
  • TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020–2024
  • TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024–2025
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 SPECIALTY ENZYMES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
  • TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
  • TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (KILOTONS)
  • TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (KILOTONS)
  • TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION,2024–2029 (USD MILLION)
  • TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS
  • TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (KILOTONS)
  • TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (KILOTONS)
  • TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
  • TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
  • TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 218 OVERVIEW OF STRATEGIES ADOPTED BY KEY SPECIALTY ENZYME VENDORS
  • TABLE 219 SPECIALTY ENZYMES MARKET: REGIONAL FOOTPRINT
  • TABLE 220 SPECIALTY ENZYMES MARKET: TYPE FOOTPRINT
  • TABLE 221 SPECIALTY ENZYMES MARKET: APPLICATION FOOTPRINT
  • TABLE 222 SPECIALTY ENZYMES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 223 SPECIALTY ENZYMES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 224 SPECIALTY ENZYMES MARKET: PRODUCT LAUNCHES, DECEMBER 2021–FEBRUARY 2024
  • TABLE 225 SPECIALTY ENZYMES MARKET: DEALS, FEBRUARY 2019–APRIL 2024
  • TABLE 226 SPECIALTY ENZYMES MARKET: OTHERS, MAY 2019–APRIL 2024
  • TABLE 227 BRAIN BIOTECH AG: BUSINESS OVERVIEW
  • TABLE 228 BRAIN BIOTECH AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 229 BRAIN BIOTECH AG: OTHERS
  • TABLE 230 NOVOZYMES A/S: BUSINESS OVERVIEW
  • TABLE 231 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 232 NOVOZYMES A/S: DEALS
  • TABLE 233 NOVOZYMES A/S: OTHERS
  • TABLE 234 CODEXIS, INC.: BUSINESS OVERVIEW
  • TABLE 235 CODEXIS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 236 CODEXIS, INC.: PRODUCT LAUNCHES
  • TABLE 237 CODEXIS, INC.: DEALS
  • TABLE 238 CODEXIS, INC.: OTHERS
  • TABLE 239 SANOFI: BUSINESS OVERVIEW
  • TABLE 240 SANOFI: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 241 SANOFI: DEALS
  • TABLE 242 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 243 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 244 MERCK KGAA: DEALS
  • TABLE 245 MERCK KGAA: OTHERS
  • TABLE 246 DYADIC INTERNATIONAL INC.: BUSINESS OVERVIEW
  • TABLE 247 DYADIC INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 248 DYADIC INTERNATIONAL INC.: DEALS
  • TABLE 249 ADVANCED ENZYME TECHNOLOGIES: BUSINESS OVERVIEW
  • TABLE 250 ADVANCED ENZYME TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 251 ADVANCED ENZYME TECHNOLOGIES: DEALS
  • TABLE 252 AMANO ENZYME INC.: BUSINESS OVERVIEW
  • TABLE 253 AMANO ENZYME INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 254 AMANO ENZYME INC.: DEALS
  • TABLE 255 AMANO ENZYME INC.: OTHERS
  • TABLE 256 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
  • TABLE 257 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 258 F. HOFFMANN-LA ROCHE LTD.: DEALS
  • TABLE 259 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
  • TABLE 260 NEW ENGLAND BIOLABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 261 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES
  • TABLE 262 NEW ENGLAND BIOLABS: DEALS
  • TABLE 263 NEW ENGLAND BIOLABS: OTHERS
  • TABLE 264 BBI SOLUTIONS: BUSINESS OVERVIEW
  • TABLE 265 BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 266 BBI SOLUTIONS: DEALS
  • TABLE 267 CREATIVE ENZYMES: BUSINESS OVERVIEW
  • TABLE 268 CREATIVE ENZYMES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 269 BIOSEUTICA: BUSINESS OVERVIEW
  • TABLE 270 BIOSEUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 271 BIOSEUTICA: DEALS
  • TABLE 272 SEKISUI DIAGNOSTICS: BUSINESS OVERVIEW
  • TABLE 273 SEKISUI DIAGNOSTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 SEKISUI DIAGNOSTICS: OTHERS
  • TABLE 275 ANTOZYME BIOTECH PVT. LTD.: BUSINESS OVERVIEW
  • TABLE 276 ANTOZYME BIOTECH PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 277 S.I. BIOZYME: BUSINESS OVERVIEW
  • TABLE 278 S.I. BIOZYME: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 279 AUMGENE BIOSCIENCES: BUSINESS OVERVIEW
  • TABLE 280 AUMGENE BIOSCIENCES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 ENZYME BIOSCIENCE: BUSINESS OVERVIEW
  • TABLE 282 ENZYME BIOSCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 283 INFINITA BIOTECH PRIVATE LIMITED: BUSINESS OVERVIEW
  • TABLE 284 INFINITA BIOTECH PRIVATE LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 285 BIOLAXI ENZYMES PVT. LTD.: BUSINESS OVERVIEW
  • TABLE 286 BIOLAXI ENZYMES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 MARKETS ADJACENT TO SPECIALTY ENZYMES MARKET
  • TABLE 288 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
  • TABLE 289 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
  • TABLE 290 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2019–2022 (USD MILLION)
  • TABLE 291 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2023–2028 (USD MILLION)
  • TABLE 292 FOOD ENZYMES MARKET, BY TYPE, 2016–2020 (USD MILLION)
  • TABLE 293 FOOD ENZYMES MARKET, BY TYPE, 2021–2026 (USD MILLION)
  • TABLE 294 FOOD ENZYMES MARKET, BY REGION, 2016–2020 (USD MILLION)
  • TABLE 295 FOOD ENZYMES MARKET, BY REGION, 2021–2026 (USD MILLION)
  • TABLE 296 FEED ENZYMES MARKET, BY REGION, 2016–2019 (USD MILLION)
  • TABLE 297 FEED ENZYMES MARKET, BY REGION, 2020–2025 (USD MILLION)
LIST OF FIGURES
 
  • FIGURE 1 MARKET SEGMENTATION
  • FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
  • FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020–2023 (USD BILLION)
  • FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 RECESSION INDICATORS
  • FIGURE 8 GLOBAL INFLATION RATE, 2013–2023
  • FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013–2023 (USD TRILLION)
  • FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
  • FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST
  • FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT
  • FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES
  • FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
  • FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018–2023 (USD BILLION)
  • FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022
  • FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000–2022 (USD MILLION)
  • FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017–2023 (USD BILLION)
  • FIGURE 26 SUPPLY CHAIN ANALYSIS
  • FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
  • FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022–2023 (USD/KG)
  • FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
  • FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM
  • FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
  • FIGURE 37 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
  • FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES
  • FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029
  • FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029
  • FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT
  • FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2022
  • FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
  • FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2022
  • FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023
  • FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT
  • FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2022
  • FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
  • FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018–2022
  • FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
  • FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017–2022
  • FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023
  • FIGURE 55 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD MILLION)
  • FIGURE 56 SPECIALTY ENZYMES MARKET: DEGREE OF COMPETITION (CONSOLIDATED)
  • FIGURE 57 SPECIALTY ENZYMES MARKET: COMPANY VALUATION (USD BILLION)
  • FIGURE 58 EV/EBITDA OF KEY PLAYERS, 2023
  • FIGURE 59 SPECIALTY ENZYMES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 60 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 61 SPECIALTY ENZYMES MARKET: COMPANY FOOTPRINT
  • FIGURE 62 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 63 BRAIN BIOTECH AG: COMPANY SNAPSHOT
  • FIGURE 64 NOVOZYMES A/S: COMPANY SNAPSHOT
  • FIGURE 65 CODEXIS, INC.: COMPANY SNAPSHOT
  • FIGURE 66 SANOFI: COMPANY SNAPSHOT
  • FIGURE 67 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 68 DYADIC INTERNATIONAL INC.: COMPANY SNAPSHOT
  • FIGURE 69 ADVANCED ENZYME TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 70 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT

This research involves the extensive use of secondary sources; directories; and databases (Bloomberg and Factiva) to identify and collect information useful for a technical, market-oriented, and commercial study of the Specialty enzymes market. In-depth interviews were conducted with various primary respondents, such as key industry participants, Subject Matter Experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.

Secondary Research

In the secondary research process, various sources, such as the European Federation of Biotechnology (EFB), American Chemical Society (ACS), Association of Manufacturers and Formulators of Enzyme Products (AMFEP), Enzyme Technical Association (ETA), International Union of Biochemistry and Molecular Biology (IUBMB), Food and Drug Administration (FDA) , Environmental Protection Agency (EPA), European Chemicals Agency (ECHA), Food Safety and Standards Authority of India (FSSAI), Ministry of Health, Labour and Welfare (MHLW) Japan associations were referred to identify and collect information for this study. The secondary sources also include journals, press releases, investor presentations of companies, whitepapers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.

Primary Research

The Specialty enzymes market encompasses various stakeholders involved in the supply chain, raw material manufacturers, raw material suppliers, regulatory organizations, and research institutions. To gather comprehensive information, primary sources from both the supply and demand sides were engaged. Primary interviewees from the supply side consisted of manufacturers, distributors, importers, and technology providers involved in the production and distribution of Enzymes. On the demand side, key opinion leaders, executives, and CEOs of companies in the Enzymes industry were approached through questionnaires, emails, and telephonic interviews. This approach ensured a comprehensive and well-rounded understanding of the Specialty enzymes market from various perspectives.

Specialty Enzymes Market Primary Research

Market Size Estimation

 The top-down and bottom-up approaches were used to estimate and validate the market’s and various dependent submarkets’ size. The research methodology used to estimate the market size includes extensive secondary research of key players, reports, reviews, and newsletters of top market players, along with extensive interviews from leaders, such as CEOs, directors, and marketing executives.

Global Specialty Enzymes Market Size: Top-Down Approach

Specialty Enzymes Market Top Down Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Specialty Enzymes Market Top Down Approach

Specialty Enzymes Market Top Down Approach

Data Triangulation

Specialty Enzymes Market Data Triangulation

Market Definition

Enzymes are proteins that are composed of amino acids and have the capability to convert a compound (substrate) into another product by catalytic reaction. These catalytic proteins assist in the performance of biochemical reactions. They lower the activation energy of the reaction and then induce it.

Specialty enzymes are primarily utilized to produce pharmaceuticals, and diagnostics solutions, as well as in bio-catalysts and research & biotechnology. They are highly selective catalysts and function in metabolic reactions and in the interconversion of complex molecules to smaller ones.

Stakeholders

  • Specialty enzyme raw material suppliers
  • Specialty enzyme manufacturers
  • Intermediate suppliers such as traders and distributors of specialty enzymes
  • Manufacturers of pharmaceuticals, research & biotechnology, diagnostics, and fine chemicals
  • Government and research organizations
  • Associations, regulatory bodies, and other industry-related bodies:
    • European Communities
    • World Health Organization (WHO)
    • Association of Manufacturers & Formulators of Enzyme Products (AMFEP)
    • OECD-FAO Agricultural Outlook
    • United States Department of Agriculture (USDA)
    • European Union (EU)
    • European Medicine Agency
    • European Federation of Pharmaceutical Industry Associations (EFPIA)
    • Medicines and Healthcare products Regulatory Agency (MHRA)
    • Central Drugs Standard Control Organization (CDSCO)
    • Ministry of Health, Labour and Welfare (MHLW)
    • National Medical Products Administration (NMPA)
    • Health Canada
    • Therapeutic Goods Administration (TGA)
    • Swiss Agency for Therapeutic Products (Swissmedic)
    • Brazilian Health Regulatory Agency (ANVISA)

Report Objectives

  • To define and measure the global specialty enzymes market with respect to type, source, application, and geography
  • Determining and projecting the size of the specialty enzymes market, with respect to product type, source, type, application, and regional markets, over a five-year period, ranging from 2024 to 2029.
  • Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • Providing detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • Analyzing the micro markets, with respect to individual growth trends, prospects, and their contribution to the total market
  • To strategically profile key players of the global specialty enzymes market and comprehensively analyze their core competencies in each segment
  • To track and analyze competitive developments, such as alliances, joint ventures, new product developments, mergers, and acquisitions in the global specialty enzymes market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to the company-specific scientific needs.

  • Further breakdown of the Rest of the European Probiotics market, by key country
  • Further breakdown of the Rest of the Asia Pacific Probiotics market, by key country
  • Further breakdown of the Rest of South America Probiotics market, by key country

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

Previous Versions of this Report

Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025

Report Code FB 2276
Published in Apr, 2020, By MarketsandMarkets™

Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025

Report Code FB 2276
Published in Mar, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Specialty Enzymes Market

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status